Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 5, 2013, Pages 2016-2025

  Newton, Dorothy F ^a   MacFarlane, Sandra ^a   MacFarlane, George T ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; METRONIDAZOLE;

ARTICLE; BACTERIAL METABOLISM; BACTERIAL VIABILITY; BACTERIUM CULTURE; BACTEROIDES THETAIOTAOMICRON; BACTEROIDES VULGATUS; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; BIFIDOBACTERIUM PSEUDOLONGUM; CELL DENSITY; CHEMOSTAT; CLOSTRIDIUM BIFERMENTANS; CLOSTRIDIUM BUTYRICUM; CLOSTRIDIUM INNOCUUM; CLOSTRIDIUM PERFRINGENS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENZYME SYNTHESIS; ESCHERICHIA COLI; HUMAN; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; NONHUMAN; PRIORITY JOURNAL;

AMPICILLIN; ANAEROBIOSIS; ANTI-INFECTIVE AGENTS; BACTEROIDES; BIFIDOBACTERIUM; BIOREACTORS; CLOSTRIDIUM; FERMENTATION; HUMANS; INTESTINE, LARGE; METAGENOME; METRONIDAZOLE; MICROBIAL CONSORTIA; MODELS, BIOLOGICAL;

EID: 84876272096     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00079-13     Document Type: Article

References (60)

1. Macfarlane GT, Gibson GR, Cummings JH. 1992. Comparison of fermentation reactions in different regions of the human colon. J. Appl. Bacteriol. 72:57-64.
2. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312:1355-1359.
3. Moore WEC, Holdeman LV. 1974. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl. Microbiol. 27:961-979.
4. Cummings J. 1981. Short chain fatty acids in the human colon. Gut 22:763-769.
5. O'Hara AM, Shanahan F. 2006. The gut flora as a forgotten organ. EMBO Rep. 7:688-693.
6. Round JL, Mazmanian SK. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nutr. Rev. Immunol. 9:313-323.
7. Macfarlane GT, Macfarlane S. 2012. Bacteria, colonic fermentation, and gastrointestinal health. J. AOAC Int. 95:50-60.
8. Chang JY, Antionpoulos DA, Kaira A, Tonelli A, Khalife WT, Schmidt TM, Young VB. 2008. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile associated diarrhea. J. Infect. Dis. 197:435-438.
9. Macfarlane S, Steed H, Macfarlane GT. 2009. Intestinal bacteria in IBD. Crit. Rev. Clin. Lab. Sci. 46:25-54.
10. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, Finlay BB. 2008. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 76:4726-4736.
11. Stecher B, Hardt W-D. 2008. The role of microbiota in infectious disease. Trends Microbiol. 16:107-114.
12. Yang L, Pei Z. 2006. Bacteria, inflammation, and colon cancer. World J. Gastroenterol. 12:6741-6746.
13. Newton DF, Cummings JH, Macfarlane S, Macfarlane GT. 1998. Growth of a human intestinal Desulfovibrio desulfuricans in continuous cultures containing defined populations of saccharolytic and amino acid fermenting bacteria. J. Appl. Microbiol. 85:372-380.
14. Bartosch S, Fite A, Macfarlane GT, McMurdo ME. 2004. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol. 70: 3575-3581.
15. Macfarlane S, Furrie E, Cummings JH, Macfarlane GT. 2004. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin. Infect. Dis. 38:1690-1699.
16. Macfarlane S, Woodmansey EJ, Macfarlane GT. 2005. Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl. Environ. Microbiol. 71:7483-7492.
17. Macfarlane S, Macfarlane GT. 2006. Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut. Appl. Environ. Microbiol. 72:6204-6211.
18. Macfarlane GT, Englyst HN. 1986. Starch utilization by the human large intestinal microflora. J. Bacteriol. 60:195-201.
19. Balch WE, Fox GE, Magrum LJ, Woese CR, Wolfe RS. 1979. Methanogens: reevaluation of a unique biological group. Microbiol. Rev. 43:260-296.
20. Beerens H. 1990. Elective and selective isolation medium for Bifidobacterium spp. Lett. Appl. Microbiol. 11:155-157.
21. Macfarlane GT, Cummings JH, Macfarlane S, Gibson GR. 1989. Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture system. J. Appl. Bacteriol. 67:521-527.
22. Macfarlane GT, Cummings JH, Allison C. 1986. Protein digestion by human intestinal bacteria. J. Gen. Microbiol. 132:1647-1665.
23. Macfarlane GT, Cummings JH, Allison C. 1988. Contribution of the microflora to proteolysis in the human large intestine. J. Appl. Bacteriol. 64:37-46.
24. Warren L. 1959. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234:1971-1975.
25. Holdeman LV, Cato EP, Moore WEC. 1977. Anaerobic laboratory manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg, VA.
26. Miller L, Berger T. 1985. Bacterial identification by gas chromatography of whole cell fatty acids, p 228-241. Hewlett-Packard application note. Hewlett-Packard, Avondale, PA.
27. Macfarlane GT, Gibson GR. 1994. Metabolic activities of the normal colonic flora, p 17-52. In Gibson SAW (ed), Human health: the contribution of microorganisms. Springer-Verlag, London, United Kingdom.
28. Finegold SM, Sutter VL, Mathisen GE. 1983. Normal indigenous intestinal flora, p 3-31. In Hentges DJ (ed), Human intestinal microflora in health and disease. Academic Press, London, United Kingdom.
29. Salyers AA. 1984. Bacteroides of the human lower intestinal tract. Annu. Rev. Microbiol. 38:293-313.
30. Gibson GR, Saavedra JM, Macfarlane S, Macfarlane GT. 1997. Gastrointestinal microbial disease and probiotics, p 10-39. In Fuller R (ed), Probiotics: therapeutic and other beneficial effect. Chapman & Hall, London, United Kingdom.
31. Gibson GR, Wang X. 1994. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J. Appl. Bacteriol. 77:412-420.
32. Van Der Waaij D, Berghuis-De Vries JM, Lekkerkerk-Van Der Wees JEC. 1971. Colonisation resistance of the digestive tract in conventional and antibiotic-treated mice. J. Hyg. 69:405-411.
33. Vollaard EJ, Clasener HA. 1994. Colonization resistance. Antimicrob. Agents Chemother. 38:409-414.
34. Bodey GP, Fainstein V, Garcia I, Rosenbaum B, Wong Y. 1983. Effects of broad-spectrum cephalosporins on the microbial flora of recipients. J. Infect. Dis. 148:892-897.
35. Kager L, Ljungdahl I, Malborg AS, Nord CE, Pieper R, Dahlgren P. 1981. Antibiotic prophylaxis with cefoxitin in colorectal surgery: effect on the colon microflora and septic complications - a clinical model for prediction of the benefit and risks in using a new antibiotic in prophylaxis. Ann. Surg. 193:227-282.
36. Mulligan ME, Citron DM, McNamara BT, Finegold SM. 1982. Impact of cefoperazone therapy on fecal flora. Antimicrob. Agents Chemother. 22:343-346.
37. Mulligan ME, Citron DM, Gabay E, Kirby BD, George EL. 1984. Alterations in human fecal flora, including ingrowth of Clostridium difficile, related to cefoxitin therapy. Antimicrob. Agents Chemother. 26:343-346.
38. Nord CE, Kager L, Heimdahl A. 1984. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am. J. Med. 76:99-106.
39. Ianniello F, Noviello S, Leone S, Esposito S, Lucisano A, Ciarcia R. 2005. Changes in intestinal microflora following levofloxacin administration in laboratory animals. Infez. Med. 13:168-174. (In Italian.)
40. Wlodarska M, Willing B, Keeney KM, Bergstrom KS, Gill N, Russell SL, Vallance BA, Finlay BB. 2011. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium- induced colitis. Infect. Immun. 79:1536-1545.
41. Freeman J, Baines SD, Jabes D, Wilcox MH. 2005. Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection. J. Antimicrob. Chemother. 56:717-725.
42. Brock TD, Madigan MT. 1991. Microbial biotechnology, p 348-386. In Brock TD (ed), Biology of microorganisms. Prentice-Hall International Inc, London, United Kingdom.
43. Midtvedt T, Carlstedt-Duke B, Hoverstadt T, Lingaas E, Norin E, Saxergolt H, Steinbaak M. 1986. Influence of peroral antibiotics upon the biotransformatory activity of the intestinal microflora in healthy subjects. Eur. J. Clin. Invest. 16:11-17.
44. Edwards DI. 1980. Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs. Br. J. Vener. Dis. 56:285-290.
45. Goldstein BP, Neilsen E, Berti M, Bolzoni G, Silvestri LG. 1977. The mechanism of action of nitro-heterocyclic antimicrobial drugs. Primary target of 1-methyl-2-nitro-5-vinylimdazole is DNA. J. Gen. Microbiol. 100:271-281.
46. Ings RMJ, McFadzean JA, Omerod WE. 1974. The mode of action of metronidazole in Trichomonas vaginalis and other microorganisms. Biochem. Pharmacol. 23:1421-1429.
47. Willson RL, Cramp WA, Ings RMG. 1974. Metronidazole ('Flagyl'): mechanisms of radiosensitization. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 26:557-569.
48. Muller M. 1983. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery 93:165-171.
49. Pendland SL, Piscitelli SC, Shreckenberger PC, Danziger LH. 1994. In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides species. Antimicrob. Agents Chemother. 38:2106-2110.
50. Scully BE. 1988. Metronidazole. Med. Clin. North Am. 72:613-621.
51. Arabi Y, Dimock F, Burdon DW, Alexander-Williams J, Keighley MR. 1979. Influence of neomycin and metronidazole on colonic microflora of volunteers. J. Antimicrob. Chemother. 5:531-537.
52. Krook A. 1981. Effect of metronidazole and sulfasalazine on the normal human fecal flora. Scand. J. Gastroenterol. 16:587-592.
53. Perez-Reyes E, Kalyanaraman B, Mason RP. 1980. The reductive metabolism of metronidazole and ronidazole by anaerobic liver microsomes. Mol. Pharmacol. 17:239-244.
54. Degnan BA, Macfarlane GT. 1994. Effect of dilution rate and carbon availability on Bifidobacterium breve fermentation. Appl. Microbiol. Biotechnol. 40:800-805.
55. Degnan BA, Macfarlane GT. 1995. Arabinogalactan utilization in continuous cultures of Bifidobacterium longum: effect of co-culture with Bacteroides thetaiotaomicron. Anaerobe 1:103-112.
56. Finegold SM, Posnick DJ, Miller LG, Hewitt WL. 1965. The effect of various antimicrobial compounds on the normal human fecal flora. Ernahrungsforschung 10:316-341.
57. Finegold SM, Davis A, Miller LG. 1967. Comparative effect of broadspectrum antibiotics on non-spore forming anaerobes and normal bowel flora. Ann. N. Y. Acad. Sci. 145:268-281.
58. Hoverstad T, Carlstedt-Duke B, Lingaas E, Midtvedt T, Norin E, Saxerholt H, Steinbakk M. 1986. Influence of ampicillin, clindamycin and metronidazole on fecal excretion of short-chain fatty acids in healthy subjects. Scand. J. Gastroenterol. 21:621-626.
59. Gibson GR, Beatty ER, Wang X, Cummings JH. 1995. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108:975-982.
60. Hopkins MJ, Macfarlane GT. 2003. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl. Environ. Microbiol. 69:1920-1927.